[go: up one dir, main page]

PE20080193A1 - PROCESO PARA LA PREPARACION DE ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO (1R), 2S-2-AMINOPROPIONICO - Google Patents

PROCESO PARA LA PREPARACION DE ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO (1R), 2S-2-AMINOPROPIONICO

Info

Publication number
PE20080193A1
PE20080193A1 PE2007000492A PE2007000492A PE20080193A1 PE 20080193 A1 PE20080193 A1 PE 20080193A1 PE 2007000492 A PE2007000492 A PE 2007000492A PE 2007000492 A PE2007000492 A PE 2007000492A PE 20080193 A1 PE20080193 A1 PE 20080193A1
Authority
PE
Peru
Prior art keywords
iloxi
methyl
compound
triazin
indol
Prior art date
Application number
PE2007000492A
Other languages
English (en)
Inventor
Gerard A Crispino
Mourad Hamedi
Thomas L Laporte
John E Thornton
Paul C Lobben
David K Leahy
Jale Muslehiddinoglu
Chiajen Lai
Lori Ann Spangler
Robert P Discordia
Zhongmin Xu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38357966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080193(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20080193A1 publication Critical patent/PE20080193A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE REFIERE A UN PROCESO MEJORADO PARA LA PREPARACION DE : ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO [(1R),2S]-2-AMINOPROPIONICO QUE COMPRENDE EN HACER REACCIONAR UN COMPUESTO DE ESTER 1-[4-OXO-5-METILPIRROLO[2,1-F][1,2,4]TRIAZIN-6-ILOXI]-METILICO DEL ACIDO ACETICO CON UN AGENTE DE METILACION EN UN SOLVENTE ADECUADO, LA CUAL PASA POR PROCESOS DE OXIDACION, REACCION DE APAGADO, PROTECCION Y CLORACION PARA UNIRSE CON UN COMPUESTO DE 2-METIL-4-FLUORO-5-HIDROXI-1H-INDOL OBTENIENDO UN COMPUESTO EL CUAL ES CRISTALIZADO, DESPROTEGIDO CON EL OXIDO DE (R)-(+)-PROPILENO, RECRISTALIZADO PARA LUEGO HACER REACCIONAR CON UN CBZ-L-ALANINA, DESPROTEGER Y CRISTALIZAR PARA OBTENER EL COMPUESTO DESCRITO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO ES INHIBIDOR DOBLE DE VEGFR Y FGFR TIROSINA CINASAS UTILES EN EL TRATAMIENTO DEL CANCER
PE2007000492A 2006-04-21 2007-04-20 PROCESO PARA LA PREPARACION DE ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO (1R), 2S-2-AMINOPROPIONICO PE20080193A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74530006P 2006-04-21 2006-04-21

Publications (1)

Publication Number Publication Date
PE20080193A1 true PE20080193A1 (es) 2008-03-10

Family

ID=38357966

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000492A PE20080193A1 (es) 2006-04-21 2007-04-20 PROCESO PARA LA PREPARACION DE ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO (1R), 2S-2-AMINOPROPIONICO

Country Status (23)

Country Link
US (1) US7671199B2 (es)
EP (1) EP2010538B1 (es)
JP (1) JP5203353B2 (es)
KR (1) KR101423789B1 (es)
CN (1) CN101472927B (es)
AR (1) AR060622A1 (es)
AU (1) AU2007240453B2 (es)
BR (1) BRPI0710691A2 (es)
CA (1) CA2650059A1 (es)
CL (2) CL2007001141A1 (es)
DK (1) DK2010538T3 (es)
EA (1) EA019693B1 (es)
ES (1) ES2399379T3 (es)
HR (1) HRP20130099T1 (es)
IL (1) IL194715A (es)
MX (1) MX2008013232A (es)
NO (1) NO20084326L (es)
PE (1) PE20080193A1 (es)
PL (1) PL2010538T3 (es)
PT (1) PT2010538E (es)
SI (1) SI2010538T1 (es)
TW (1) TWI378100B (es)
WO (1) WO2007124332A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101291934B (zh) * 2005-09-27 2012-06-27 布里斯托尔-迈尔斯·斯奎布公司 [(1R),2S]-2-氨基丙酸2-[4-(4-氟-2-甲基-1H-吲哚-5-基氧基)-5-甲基吡咯并[2,1-f][1,2,4]三嗪-6-基氧基]-1-甲基乙基酯的晶型
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
AR074830A1 (es) 2008-12-19 2011-02-16 Cephalon Inc Pirrolotriazinas como inhibidores de alk y jak2
WO2020074863A1 (en) 2018-10-08 2020-04-16 Applied Photophysics Limited System and method for analysing the composition of a quenched flow reaction liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
US6933386B2 (en) * 2002-07-19 2005-08-23 Bristol Myers Squibb Company Process for preparing certain pyrrolotriazine compounds
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7393667B2 (en) * 2005-05-31 2008-07-01 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
CN101291934B (zh) * 2005-09-27 2012-06-27 布里斯托尔-迈尔斯·斯奎布公司 [(1R),2S]-2-氨基丙酸2-[4-(4-氟-2-甲基-1H-吲哚-5-基氧基)-5-甲基吡咯并[2,1-f][1,2,4]三嗪-6-基氧基]-1-甲基乙基酯的晶型

Also Published As

Publication number Publication date
AR060622A1 (es) 2008-07-02
BRPI0710691A2 (pt) 2011-08-23
CL2010000554A1 (es) 2010-10-15
DK2010538T3 (da) 2013-03-18
IL194715A (en) 2013-10-31
JP2009534413A (ja) 2009-09-24
US20070249610A1 (en) 2007-10-25
EP2010538A1 (en) 2009-01-07
US7671199B2 (en) 2010-03-02
NO20084326L (no) 2008-11-18
AU2007240453B2 (en) 2012-04-12
SI2010538T1 (sl) 2013-06-28
KR101423789B1 (ko) 2014-07-30
MX2008013232A (es) 2008-10-21
ES2399379T3 (es) 2013-04-01
HRP20130099T1 (hr) 2013-03-31
CN101472927B (zh) 2012-07-04
JP5203353B2 (ja) 2013-06-05
CA2650059A1 (en) 2007-11-01
EP2010538B1 (en) 2012-12-05
KR20090008246A (ko) 2009-01-21
TW200808799A (en) 2008-02-16
PT2010538E (pt) 2013-02-22
PL2010538T3 (pl) 2013-04-30
AU2007240453A1 (en) 2007-11-01
TWI378100B (en) 2012-12-01
EA200802171A1 (ru) 2009-08-28
CL2007001141A1 (es) 2008-01-18
WO2007124332A1 (en) 2007-11-01
CN101472927A (zh) 2009-07-01
EA019693B1 (ru) 2014-05-30

Similar Documents

Publication Publication Date Title
WO2008084223A3 (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
PE20100716A1 (es) Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
EA200702549A1 (ru) Способ производства органического соединения
MA32941B1 (fr) Composes organiques
TW200800997A (en) Chemical compounds
AR066709A1 (es) Proceso para la produccion de pirazoles
AR055993A1 (es) Proceso para producir 3-oxo-pregnano-21,17-carbolactonas, asi como 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion del correspondiente 17-(3-hidroxipropil)-3,17-dihidroxiandrostano
PE20080193A1 (es) PROCESO PARA LA PREPARACION DE ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO (1R), 2S-2-AMINOPROPIONICO
CO6220977A2 (es) Sintesis total de salinosporamida a y analogos de las misma
MA31094B1 (fr) Utilisation de dérivés de pyranone-acide substituée pour le traitement du syndrome métabolique
SE0300850D0 (sv) Chemical compounds
AR063415A1 (es) Hidratos de clorhidrato de erlotinib para el tratamiento del cancer
CN103073536A (zh) 一种艾普拉唑的制备方法
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
WO2008105464A1 (ja) カルボン酸クロライドの製造方法
Das et al. An efficient synthesis of vinyl sulfones from alkenes and aryl sulfinates
BRPI1008308B8 (pt) processo para produzir um composto
AR068801A1 (es) Proceso para la produccion de un compuesto de toluidina como ingrediente activo de plaguicidas
TW200745106A (en) Chemical compounds
AR093373A1 (es) Procedimiento de sintesis del (2e)-3-(3,4-dimetoxifenil)prop-2-enonitrilo y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
AR050931A1 (es) Un procedimiento para fabricar compuestos enantiomericos del imidazol que comprenden el r- sertaconazol y compuesto obtenido
TW200800942A (en) Chemical compounds
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
CU20220049A7 (es) Forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato, método para su preparación y composiciones farmacéuticas que la comprenden

Legal Events

Date Code Title Description
FD Application declared void or lapsed